This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB07357/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07357/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07357/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07357/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07357/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07357
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07357 n11:DB07357
dcterms:title
4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
adms:identifier
n8:395137 n9:DB07357 n12:99443828 n13:AIG n14:448295
n3:IUPAC-Name
n4:271B6395-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B639B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B639A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6397-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6398-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6399-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6393-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6391-363D-11E5-9242-09173F13E4C5 n4:271B6394-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6392-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B63A1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B63A2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B639C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B639D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B639F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B639E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B63A0-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B63A7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B63A9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B63AA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B63A6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B63A5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B63A8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6396-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B63A3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B63A4-363D-11E5-9242-09173F13E4C5